250 related articles for article (PubMed ID: 27895119)
21. Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue.
Simpson J; Rezaie P; Newcombe J; Cuzner ML; Male D; Woodroofe MN
J Neuroimmunol; 2000 Aug; 108(1-2):192-200. PubMed ID: 10900353
[TBL] [Abstract][Full Text] [Related]
22. Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198.
Lau G; Labrecque J; Metz M; Vaz R; Fricker SP
J Biol Chem; 2015 Apr; 290(17):11041-51. PubMed ID: 25767113
[TBL] [Abstract][Full Text] [Related]
23. Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers.
El-Asmar L; Springael JY; Ballet S; Andrieu EU; Vassart G; Parmentier M
Mol Pharmacol; 2005 Feb; 67(2):460-9. PubMed ID: 15509716
[TBL] [Abstract][Full Text] [Related]
24. Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine.
Andres PG; Beck PL; Mizoguchi E; Mizoguchi A; Bhan AK; Dawson T; Kuziel WA; Maeda N; MacDermott RP; Podolsky DK; Reinecker HC
J Immunol; 2000 Jun; 164(12):6303-12. PubMed ID: 10843684
[TBL] [Abstract][Full Text] [Related]
25. Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis.
Shahrara S; Amin MA; Woods JM; Haines GK; Koch AE
Arthritis Rheum; 2003 Dec; 48(12):3568-83. PubMed ID: 14674010
[TBL] [Abstract][Full Text] [Related]
26. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.
Mack M; Cihak J; Simonis C; Luckow B; Proudfoot AE; Plachý J; Brühl H; Frink M; Anders HJ; Vielhauer V; Pfirstinger J; Stangassinger M; Schlöndorff D
J Immunol; 2001 Apr; 166(7):4697-704. PubMed ID: 11254730
[TBL] [Abstract][Full Text] [Related]
27. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
28. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
29. Chemokines as regulators of T cell differentiation.
Luther SA; Cyster JG
Nat Immunol; 2001 Feb; 2(2):102-7. PubMed ID: 11175801
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5.
Ortiz Zacarías NV; van Veldhoven JPD; den Hollander LS; Dogan B; Openy J; Hsiao YY; Lenselink EB; Heitman LH; IJzerman AP
J Med Chem; 2019 Dec; 62(24):11035-11053. PubMed ID: 31742400
[TBL] [Abstract][Full Text] [Related]
31. Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways.
Blanpain C; Wittamer V; Vanderwinden JM; Boom A; Renneboog B; Lee B; Le Poul E; El Asmar L; Govaerts C; Vassart G; Doms RW; Parmentier M
J Biol Chem; 2001 Jun; 276(26):23795-804. PubMed ID: 11323418
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of chemotaxis: role of Gβγ in chemokine receptor-induced cell migration.
Kerr JS; Jacques RO; Moyano Cardaba C; Tse T; Sexton D; Mueller A
Cell Signal; 2013 Apr; 25(4):729-35. PubMed ID: 23277202
[TBL] [Abstract][Full Text] [Related]
33. TLR2-dependent pathway of heterologous down-modulation for the CC chemokine receptors 1, 2, and 5 in human blood monocytes.
Fox JM; Letellier E; Oliphant CJ; Signoret N
Blood; 2011 Feb; 117(6):1851-60. PubMed ID: 21148810
[TBL] [Abstract][Full Text] [Related]
34. Small molecule receptor agonists and antagonists of CCR3 provide insight into mechanisms of chemokine receptor activation.
Wise EL; Duchesnes C; da Fonseca PC; Allen RA; Williams TJ; Pease JE
J Biol Chem; 2007 Sep; 282(38):27935-43. PubMed ID: 17635911
[TBL] [Abstract][Full Text] [Related]
35. Differential involvement of Galpha16 in CC chemokine-induced stimulation of phospholipase Cbeta, ERK, and chemotaxis.
Tian Y; Lee MM; Yung LY; Allen RA; Slocombe PM; Twomey BM; Wong YH
Cell Signal; 2008 Jun; 20(6):1179-89. PubMed ID: 18406577
[TBL] [Abstract][Full Text] [Related]
36. Allosteric effects of antagonists on signalling by the chemokine receptor CCR5.
Haworth B; Lin H; Fidock M; Dorr P; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):891-7. PubMed ID: 17669370
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
38. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
Sanchez J; Lane JR; Canals M; Stone MJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
[TBL] [Abstract][Full Text] [Related]
39. FROUNT is a common regulator of CCR2 and CCR5 signaling to control directional migration.
Toda E; Terashima Y; Sato T; Hirose K; Kanegasaki S; Matsushima K
J Immunol; 2009 Nov; 183(10):6387-94. PubMed ID: 19841162
[TBL] [Abstract][Full Text] [Related]
40. Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist.
Isaikina P; Tsai CJ; Dietz N; Pamula F; Grahl A; Goldie KN; Guixà-González R; Branco C; Paolini-Bertrand M; Calo N; Cerini F; Schertler GFX; Hartley O; Stahlberg H; Maier T; Deupi X; Grzesiek S
Sci Adv; 2021 Jun; 7(25):. PubMed ID: 34134983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
